Literature DB >> 12571342

Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

C Watkins1, I Harvey, P Carthy, L Moore, E Robinson, R Brawn.   

Abstract

BACKGROUND: General practitioner (GP) prescribing accounts for about 10% of NHS expenditure. GPs at the top of the range have annual prescribing costs that are almost twice as much as those at the bottom of the range. This variation cannot be accounted for purely in terms of differences in underlying need for health care.
OBJECTIVES: To describe the relationship between GPs' prescribing costs and their attitudes towards prescribing decisions and prescribing information sources, and to identify potentially modifiable attitudinal and behavioural factors associated with high cost prescribing.
DESIGN: A postal questionnaire was designed on the basis of hypotheses developed from a literature search and an earlier qualitative survey. This questionnaire was sent to a national sample of GPs with equal numbers of practices in the upper, middle, and lowest quintile of prescribing costs.
SETTING: GP practices in England. PARTICIPANTS: 1714 GPs in NHS practice. OUTCOME MEASURES: GPs' self-reported practices, attitudes and personal characteristics.
RESULTS: There was a 64% response rate. Responders were more likely to be from larger practices, in less deprived areas, and with lower prescribing costs than were non-responders. Multivariable analysis showed that GPs with high prescribing costs were significantly more likely to work in dispensing practices, in practices with low income populations, in single handed practices, and in practices without a GP trainer. They were also significantly more likely to see drug company representatives more frequently, to prescribe newly available drugs more freely, to prescribe more readily to patients who expect a prescription, to report high levels of frustration from lack of time in the consultation, to find unsatisfactory those consultations which ended in advice only, and to express dissatisfaction with their review methods for repeat prescribing. They were significantly less likely to find useful criticism of prescribing habits by colleagues, and to check the BNF rather than other sources when uncertain about an aspect of drug treatment.
CONCLUSIONS: While they cannot be held to have a causal relationship, the pattern of attitudes towards prescribing of GPs in the highest quintile of prescribing costs provide the basis for developing an educational intervention which may be an acceptable method of modifying the attitudes of GPs and consequently reducing their prescribing costs.

Entities:  

Mesh:

Year:  2003        PMID: 12571342      PMCID: PMC1743655          DOI: 10.1136/qhc.12.1.29

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  19 in total

1.  Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs.

Authors:  S Rodgers; A J Avery; D Meechan; S Briant; M Geraghty; K Doran; D K Whynes
Journal:  Br J Gen Pract       Date:  1999-09       Impact factor: 5.386

2.  Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues?

Authors:  A J Avery; R V Wetzels; S Rodgers; C O'Neill
Journal:  Br J Gen Pract       Date:  2000-02       Impact factor: 5.386

3.  A study of factors associated with cost and variation in prescribing among GPs.

Authors:  P Carthy; I Harvey; R Brawn; C Watkins
Journal:  Fam Pract       Date:  2000-02       Impact factor: 2.267

4.  Physician motivations for nonscientific drug prescribing.

Authors:  R K Schwartz; S B Soumerai; J Avorn
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

5.  Clinical judgement and antibiotic use in general practice.

Authors:  J G Howie
Journal:  Br Med J       Date:  1976-10-30

6.  Can rational prescribing be assessed?

Authors:  T D van Zwanenberg; G B Grant; D A Gregory
Journal:  J R Coll Gen Pract       Date:  1987-07

7.  Correlates of physicians' prescribing behavior.

Authors:  M H Becker; P D Stolley; L Lasagna; J D McEvilla; L M Sloane
Journal:  Inquiry       Date:  1972-09       Impact factor: 1.730

8.  Differences among practitioners in patterns of preference for information sources in the adoption of new drugs.

Authors:  M Y Peay; E R Peay
Journal:  Soc Sci Med       Date:  1984       Impact factor: 4.634

9.  Patterns of physicians' use of medical resources in ambulatory settings.

Authors:  R M Hartley; J R Charlton; C M Harris; B Jarman
Journal:  Am J Public Health       Date:  1987-05       Impact factor: 9.308

10.  Drug prescribing: a discussion of its variability and (ir)rationality.

Authors:  G Carrin
Journal:  Health Policy       Date:  1987-02       Impact factor: 2.980

View more
  35 in total

1.  Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study.

Authors:  Chris Watkins; Laurence Moore; Ian Harvey; Patricia Carthy; Elizabeth Robinson; Richard Brawn
Journal:  BMJ       Date:  2003-05-31

2.  A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Authors:  Klaus Lieb; Simone Brandtönies
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

3.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

4.  Pharmaceutical care and its relationship to prescribing behaviour of general practitioners.

Authors:  Paul E M Muijrers; Richard P T M Grol; Jildou Sijbrandij; Rob Janknegt; J André Knottnerus
Journal:  Pharm World Sci       Date:  2006-11-17

5.  Temporal and within practice variability in the health improvement network.

Authors:  Kevin Haynes; Warren B Bilker; Tom R Tenhave; Brian L Strom; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-13       Impact factor: 2.890

6.  Promotional methods used by representatives of drug companies: a prospective survey in general practice.

Authors:  Jesper Schramm; Morten Andersen; Kirstin Vach; Jakob Kragstrup; Jens Peter Kampmann; Jens Søndergaard
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

Review 7.  Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies.

Authors:  Brian Godman; Alan Haycox; Ulrich Schwabe; Roberta Joppi; Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  General practitioners and pharmaceutical sales representatives: quality improvement research.

Authors:  Geoffrey Spurling; Peter Mansfield
Journal:  Qual Saf Health Care       Date:  2007-08

9.  Treatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Nam.

Authors:  Dang Duc Anh; Arthorn Riewpaiboon; Le Huu Tho; Soon Ae Kim; Batmunkh Nyambat; Paul Kilgore
Journal:  J Health Popul Nutr       Date:  2010-10       Impact factor: 2.000

10.  Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey.

Authors:  Mamas Theodorou; Vasiliki Tsiantou; Andreas Pavlakis; Nikos Maniadakis; Vasilis Fragoulakis; Elpida Pavi; John Kyriopoulos
Journal:  BMC Health Serv Res       Date:  2009-08-20       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.